Suppr超能文献

新型苯并咪唑-吡唑杂化物的合成、表征、抗溃疡作用及分子对接评估

Synthesis, characterization, anti-ulcer action and molecular docking evaluation of novel benzimidazole-pyrazole hybrids.

作者信息

Noor Abida, Qazi Neelum Gul, Nadeem Humaira, Khan Arif-Ullah, Paracha Rehan Zafar, Ali Fawad, Saeed Adil

机构信息

Department of Pharmaceutical Chemistry, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.

Department of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.

出版信息

Chem Cent J. 2017 Sep 2;11(1):85. doi: 10.1186/s13065-017-0314-0.

Abstract

A series of six novel benzimidazole-pyrazole hybrid molecules was synthesized and characterized using elemental analysis (CHN) and spectroscopic methods (HNMR, FT-IR). All the synthesized compounds were evaluated for their in vivo anti ulcerogenic activity using Albino rats (weighing 180-220 g). The interactions between the compounds and active site residues of H/K ATPase were investigated by molecular docking studies using autodock vina 4.0. SCH28080 was used to validate the docking results. Also the drug likeliness of these compounds was predicted using Molinspiration server in light of Lipinski's rule of five. All the six synthesized compounds exhibited higher anti-ulcer activity as compared to omeprazole. These novel hybrid compounds showed comparable anti-ulcer potential of 72-83% at dose level of 500 µg/kg, whereas omeprazole showed 83% anti-ulcer activity at dose level of 30 mg/kg. The results clearly indicate that these novel benzimidazole-pyrazole hybrids can present a new class of potential anti ulcer agents and can serve as new anti-ulcer drugs after further investigation. Graphical abstract An overveiw of synthesis, in silico and in vivo antiulcer screening of benzimidazole pyrazole hybrids.

摘要

合成了一系列六种新型苯并咪唑 - 吡唑杂化分子,并通过元素分析(CHN)和光谱方法(HNMR、FT - IR)对其进行了表征。使用白化大鼠(体重180 - 220克)对所有合成化合物的体内抗溃疡活性进行了评估。通过使用Autodock vina 4.0进行分子对接研究,研究了这些化合物与H/K ATP酶活性位点残基之间的相互作用。使用SCH28080验证对接结果。此外,根据Lipinski的五规则,使用Molinspiration服务器预测了这些化合物的药物相似性。与奥美拉唑相比,所有六种合成化合物均表现出更高的抗溃疡活性。这些新型杂化化合物在500μg/kg剂量水平下显示出72 - 83%的可比抗溃疡潜力,而奥美拉唑在30mg/kg剂量水平下显示出83%的抗溃疡活性。结果清楚地表明,这些新型苯并咪唑 - 吡唑杂化物可以成为一类新的潜在抗溃疡药物,经过进一步研究后可作为新型抗溃疡药物。图形摘要 苯并咪唑吡唑杂化物的合成、计算机模拟和体内抗溃疡筛选概述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e95/5581743/9b2a6a697af8/13065_2017_314_Figa_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验